Curis Competitors and Similar CompaniesClear all
Intrepida Bio's competitors and similar companies include MaxiVAX and FoRx Therapeutics.
 Intrepida Bio Intrepida Bio is a company that develops medicines intended to modulate the innate immune system to fight cancer and other diseases. |  MaxiVAX MaxiVAX is a company that develops a personalized anti-cancer vaccination designed to build immunity against cancer. |  FoRx Therapeutics FoRx Therapeutics is a company that develops cancer drugs intended to focus on novel DNA Replication Stress pathways activated in cancer. | |
Founding Date | Founding Date 2019 | Founding Date 2013 | Founding Date 2019 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations San Diego, US HQ | Locations Genève, CH HQ Genève, CH | Locations Basel, CH HQ |
Employees | Employees N/A | Employees 5 | Employees 343% increase |
Funding | |||
Latest funding round | Latest funding round $ 9.5m (over 6 years ago) | Latest funding round $ 5m (over 6 years ago) | Latest funding round $ 10.8m (about 6 years ago) |
Total funding raised | Total funding raised $ 9.5m | Total funding raised $ 8.1m | Total funding raised $ 10.8m |
For sources of this data, please see the company profile
View Company Profiles
MaxiVAX
HQ
Genève, CH
Employees
5
MaxiVAX is a company that develops a personalized anti-cancer vaccination designed to build immunity against cancer.
View companyFoRx Therapeutics
HQ
Basel, CH
Employees
34↑ 3% increase
FoRx Therapeutics is a company that develops cancer drugs intended to focus on novel DNA Replication Stress pathways activated in cancer.
View company